C. elegans : a prominent platform for modeling and drug screening in neurological disorders

INTRODUCTION: , has emerged as a benchmark model for biological research, especially in the field of neuroscience. AREAS COVERED: for the study of NDevDs and NDegDs. Specifically, the authors underscore their strong applicability in preclinical drug development. Furthermore, they place particular emphasis on detailing the common techniques employed to explore the nervous system in both healthy and diseased states. EXPERT OPINION: as a platform to replicate nervous system pathologies and conduct high-throughput automated assays in the initial phases of drug discovery is pivotal for rendering therapeutic options more attainable and cost-effective.